Related Experiment Video

Updated: May 4, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 23, 2010

12.2K

Understanding the Role of Rho GTPase Activating Protein and Bone Marrow Kinase X: A Novel Target in Gastric Cancer

Zakari Shaibu1,2, Zhihong Chen2, Fumeng Yang1

  • 1School of Medicine, Jiangsu University, Zhenjiang, Jiangsu,212013, China.

Asian Pacific Journal of Cancer Prevention : APJCP
|March 29, 2025
PubMed
Abstract

Insights

Rho GTPase Activating Protein (ARHGAP) and Bone Marrow Kinase X (BMX) are elevated in gastric cancer (GC), indicating poor prognosis. These proteins show potential as therapeutic targets for GC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Gastric cancer (GC) remains a significant global health challenge.
  • Understanding the molecular mechanisms driving GC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To review the role of Rho GTPase Activating Protein (ARHGAP) and Bone Marrow Kinase X (BMX) in gastric cancer (GC) development and progression.
  • To evaluate ARHGAP and BMX as potential therapeutic targets for GC.

Main Methods:

  • A comprehensive literature review was performed.
  • Assessed evidence on ARHGAP and BMX involvement in GC, including expression, prognosis, and tumor behavior.

Main Results:

  • Both ARHGAP and BMX are upregulated in GC tissues.
  • Elevated levels correlate with poor prognosis and aggressive tumor characteristics.
  • These proteins are implicated in GC progression mechanisms.

Conclusions:

  • ARHGAP and BMX play critical roles in gastric cancer.
  • They represent promising therapeutic targets for future GC treatment strategies.
  • Further research is needed to elucidate their precise mechanisms and therapeutic viability.
Keywords:
ARHGAP family genesBMX proteinRho GTPase activating proteinStomach Neoplasmgene fusion

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

9.1K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.4K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K